Skip To Main Content
Barry Moran on Muck Rack

Barry Moran

As seen in: Nature, The Sun, Wiley Online Library, The Irish Sun, BiggerPockets
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barry

Contact Barry, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Serum and adipose tissue-derived extracellular vesicles as biomarker reservoirs in oesophageal adenocarcinoma

|
By Aisling B. Heeran, Gary Hannon, Barry Moran, Aisling Ui Mhaonaigh, Valéria Lima Passos, Meghana Menon, Anshul Bhardwaj, John Reynolds, Adriele Prina-Mello, Simone Marcone, Narayanasamy Ravi
| Nature Verified
Abstract Oesophageal adenocarcinoma (OAC) is a highly aggressive malignancy with poor survival rates and rising global incidence. Despite research advances, no validated liquid biopsy biomarkers currently exist for OAC. Extracellular vesicles (EV), due to their role in intercellular communication and ability to carry molecular cargo, represent a promising source of diagnostic and prognostic biomarkers.
Open in Who Shared Issue with article?

26 Violet Ln, Commack, NY 11725, US

|
By Barry Moran
| BiggerPockets Verified
Investment Summary Net Operating Income (NOI) minus mortgage payments. Calculation: NOI - Mortgage Payments Monthly Cash Flow -$1,245 Capitalization Rate is a rate of return that compares the yearly Net Operating Income (NOI) to the market value. Calculation: NOI / Market Value Cap Rate 3.8% Annual Cash Flow / Cash Invested Calculation: Annual cash flow divided by initial cash invested. Cash-on-Cash Return -10.0% Net Operating Income (NOI) divided by total debt payments.
Open in Who Shared View Duplicates (693) Issue with article?

Towards Personalised Therapy in Chronic Spontaneous Urticaria: Advancing From Endotype to Clinical Response

|
By Katie Ridge, RIzwan Ahmad, Rizwan Ahmad, Barry Moran, Cliona O'Farrelly
| Wiley Online Library Verified
Chronic spontaneous urticaria (CSU) is a heterogeneous disease. Endotype-based classification is helpful, but distinctions are nuanced and some patients do not fit defined categories. Focusing on accessible biomarkers to predict response to current and emerging CSU treatments is essential. 1 Chronic Spontaneous Urticaria Chronic spontaneous urticaria (CSU) is a skin condition characterised by recurring episodes of hives lasting longer than 6 weeks [1].
Open in Who Shared Issue with article?
See all 6 articles